What is UBS's price target for XPEV?

UBS's latest stated price target for XPeng Inc. (XPEV) is $18, from its action on Feb 24, 2025.

What is UBS's rating on XPEV?

UBS rates XPEV Neutral, a neutral rating, as of Sep 9, 2026.

When did UBS last change its view on XPEV?

On Sep 9, 2026, UBS starts coverage at Neutral.

UBS XPEV price target and rating history

UBS rates XPeng Inc. (XPEV) Neutral with a $18 price target, as of its latest action on Sep 9, 2026. It has published 5 rating actions on XPEV since November 2022, including 2 upgrades and 2 downgrades.

Current rating: Neutral
Price target: $18
Median target, all firms: Too few
Actions on XPEV: 5

UBS price target on XPEV

UBS price target on XPEV, each point a stated target, November 2022 to February 2025.

Every UBS rating on XPEV

Sep 9, 2026
InitiateUBS starts coverage at Neutral
Feb 24, 2025
UpgradeUBS upgrades to Neutral from Sell, price target $8.80 to $18
Dec 5, 2024
DowngradeUBS downgrades to Sell from Neutral
Jul 31, 2023
DowngradeUBS downgrades to Neutral from Buy, price target $23
Nov 17, 2022
UpgradeUBS upgrades to Buy from Neutral, price target $34 to $13

How other firms rate XPEV

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
UBS	Neutral		Sep 9, 2026
Macquarie	Outperform	$19	May 29, 2026
BNP Paribas Exane	Underperform		Apr 22, 2026
Daiwa	Buy	$29	Nov 18, 2025

Questions about UBS and XPEV

What is UBS's price target for XPEV?: UBS's latest stated price target for XPeng Inc. (XPEV) is $18, from its action on Feb 24, 2025.
What is UBS's rating on XPEV?: UBS rates XPEV Neutral, a neutral rating, as of Sep 9, 2026.
When did UBS last change its view on XPEV?: On Sep 9, 2026, UBS starts coverage at Neutral.

More XPEV rating histories

All UBS ratings XPEV news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.